VIYASHNSEViyash Scientific LimitedMediumNeutral
Announced Sat, 30 Aug · 21:43 IST

Proceedings for NCLT convened Meeting for Unsecured Trade Creditors

Nclt Scheme FiledStrategic Transactions View source PDF

VIYASH · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve

Awaiting price reaction for this filing.

AI summary

SeQuent Scientific Limited held a meeting of its Unsecured Trade Creditors on August 30, 2025, as directed by the NCLT Hyderabad Bench-II via its Order dated July 23, 2025. The meeting was held via video conferencing to consider and approve a Composite Scheme of Amalgamation involving SeQuent Scientific, Symed Labs, and eight other related entities (including Viyash Life Sciences, Vandana Life Sciences, Appcure Labs, Vindhya Pharma, S.V. Labs, Vindhya Organics, Geninn Life Sciences, and Sequent Research) along with their shareholders and creditors. The resolution approving the scheme was passed with the requisite majority. The Managing Director briefed creditors on the rationale, share exchange ratios, and benefits of the proposed amalgamation. Voting results have been submitted to the stock exchanges under SEBI LODR Regulation 44(3).

Likely market impact

This is a key procedural milestone in the NCLT approval process for SeQuent Scientific's major group restructuring. Creditor approval moves the scheme closer to final NCLT sanction, which could lead to significant consolidation within the SeQuent group and impact shareholding structure upon completion.